3 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 17781173 | NEW USE OF REGEND001 CELL AUTOLOGOUS DELIVERABLE PREPARATION IN TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | TICHY, JENNIFER M.H. | 1653 | Final Rejection | May 31, 2022 |
| 17619591 | METHOD FOR CULTURING URINE-DERIVED KIDNEY STEM CELLS AND USE THEREOF | SCHUBERG, LAURA J | 1631 | Non-Final OA | Dec 16, 2021 |
| 17609571 | CLINICAL-GRADE AUTOLOGOUS BRONCHIAL BASAL CELL, DELIVERABLE FORMULATION, AND PREPARATION PROCESS | BEHARRY, ZANNA MARIA | 1632 | Final Rejection | Nov 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial